Recently Viewed
Clear AllQuality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Bidding Date
11-Nov-2025 to
13-Nov-2025
Issue Size
₹70.44 Cr
Price Band
₹108 to ₹114
Allotment date
14-Nov-2025
Listing date
18-Nov-2025
Lot size
1200
No. of shares
61,78,800
Fresh issue/OFS
₹64.28 Cr/₹6.16 Cr
Mahamaya Lifesciences Ltd., established in 2002 and headquartered in Gurugram, Haryana, is a leading agrochemical company specializing in the manufacturing, registration, and export of crop protection products and bioproducts. The company began by importing and registering key pesticide molecules not produced in India and subsequently expanded into manufacturing high-quality technical formulations and pesticide products, serving agricultural markets across India and exporting to countries such as Turkey, Egypt, and the UAE. Mahamaya's core business spans insecticides, fungicides, herbicides, and plant growth regulators, with expertise in providing environmentally compatible and effective crop protection solutions. The company stands out for its collaboration with the Central Insecticides Board and Registration Committee, proprietary registration capabilities, and commitment to sustainable agriculture. It engages clients through transparent practices, comprehensive product support, and a focus on innovation to meet evolving agricultural challenges while maintaining quality and reliability across diverse geographies.
Category
Status
QIBs
1.2x
NIIs
3x
Retail
1x
Others
--
Total
1.6x
The issue size of Mahamaya Lifesciences is ₹70.44 Cr.
Mahamaya Lifesciences falls into Other Chemicals industry.
The Mahamaya Lifesciences IPO will be listed on NSE.
The open and close dates for the Mahamaya Lifesciences are 11-Nov-2025 & 13-Nov-2025.
The price band for the Mahamaya Lifesciences ipo is ₹108 to ₹114
The listing date of Mahamaya Lifesciences IPO is 18-Nov-2025.
The purpose of this IPO is to raise fresh capital as well as enable the existing shareholders to sell their stake.
Mahamaya Lifesciences total subscription ratio is 1.6X.
Key financial of the Mahamaya Lifesciences are:
| Mahamaya Lifesciences | FY-25 | FY-24 | FY-23 |
|---|---|---|---|
| Revenue (₹ Cr) | 264.15 | 161.57 | 137.08 |
| EBIT (₹ Cr) | 21.47 | 11.99 | 7.86 |
| Proft after Tax (₹ Cr) | 12.94 | 5.22 | 3.75 |
| Debt (₹ Cr) | 58.11 | 54.63 | 24.37 |
| Net Worth (₹ Cr) | 49.42 | 24.66 | 19.44 |
| RoE (%) | 26.19 | 21.16 | 19.29 |